Literature DB >> 659460

The characteristics of juvenile idiopathic scoliosis and results of its treatment.

V T Tolo, R Gillespie.   

Abstract

Fifty-nine children with juvenile idiopathic scoliosis have been reviewed. In six of eighteen who had no treatment the curvatures did not increase over eighteen months or more, while in twelve they increased at a median annual rate of six degrees. The pattern and magnitude of the curvature and the age at diagnosis could not be used accurately to predict progression. In forty-two patients progression occurred and Milwaukee brace treatment was begun, thirty being managed with periods of part-time wear. The median correction was 13 per cent. Serial measurements of the rib-vertebra angle difference (RVAD) were useful to predict a tendency to progress. Part-time wear of the brace was successful in cases where the RVAD values fell towards zero or became negative with treatment. Sixteen patients required surgical treatment; all had high positive RVAD values. However, with the plan of brace treatment outlined, part-time wear controlled many of the curvatures.

Entities:  

Mesh:

Year:  1978        PMID: 659460     DOI: 10.1302/0301-620X.60B2.659460

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  18 in total

Review 1.  [Dynamic instrumentation techniques in early-onset scoliosis].

Authors:  F Geiger; M Rauschmann
Journal:  Orthopade       Date:  2009-02       Impact factor: 1.087

Review 2.  Serial elongation-derotation-flexion casting for children with early-onset scoliosis.

Authors:  Federico Canavese; Antoine Samba; Alain Dimeglio; Mounira Mansour; Marie Rousset
Journal:  World J Orthop       Date:  2015-12-18

Review 3.  Serial elongation derotation flexion casting in children with infantile and juvenile scoliosis.

Authors:  Federico Canavese; Alain Dimeglio
Journal:  Ann Transl Med       Date:  2020-01

4.  Serial elongation, derotation and flexion (EDF) casting under general anesthesia and neuromuscular blocking drugs improve outcome in patients with juvenile scoliosis: preliminary results.

Authors:  Federico Canavese; Alexei Botnari; Alain Dimeglio; Antoine Samba; Bruno Pereira; Adeline Gerst; Marie Granier; Marie Rousset; Jean Dubousset
Journal:  Eur Spine J       Date:  2015-07-10       Impact factor: 3.134

5.  Idiopathic scoliosis: prognostic value of the profile.

Authors:  R M Castelein; B Veraart
Journal:  Eur Spine J       Date:  1992-12       Impact factor: 3.134

6.  SpineCor treatment for Juvenile Idiopathic Scoliosis: SOSORT award 2010 winner.

Authors:  Christine Coillard; Alin B Circo; Charles H Rivard
Journal:  Scoliosis       Date:  2010-11-10

7.  Scoliosis: Review of diagnosis and treatment.

Authors:  Joseph A Janicki; Benjamin Alman
Journal:  Paediatr Child Health       Date:  2007-11       Impact factor: 2.253

8.  Rib-vertebral angle measurements predict brace treatment outcome in Risser grade 0 and premenarchal girls with adolescent idiopathic scoliosis.

Authors:  Xu Sun; Qi Ding; Shifu Sha; Saihu Mao; Feng Zhu; Zezhang Zhu; Bangping Qian; Bin Wang; Jack C Y Cheng; Yong Qiu
Journal:  Eur Spine J       Date:  2016-01-23       Impact factor: 3.134

Review 9.  2016 SOSORT guidelines: orthopaedic and rehabilitation treatment of idiopathic scoliosis during growth.

Authors:  Stefano Negrini; Sabrina Donzelli; Angelo Gabriele Aulisa; Dariusz Czaprowski; Sanja Schreiber; Jean Claude de Mauroy; Helmut Diers; Theodoros B Grivas; Patrick Knott; Tomasz Kotwicki; Andrea Lebel; Cindy Marti; Toru Maruyama; Joe O'Brien; Nigel Price; Eric Parent; Manuel Rigo; Michele Romano; Luke Stikeleather; James Wynne; Fabio Zaina
Journal:  Scoliosis Spinal Disord       Date:  2018-01-10

10.  Vitamin D receptor gene (VDR) transcripts in bone, cartilage, muscles and blood and microarray analysis of vitamin D responsive genes expression in paravertebral muscles of juvenile and adolescent idiopathic scoliosis patients.

Authors:  Roman Nowak; Justyna Szota; Urszula Mazurek
Journal:  BMC Musculoskelet Disord       Date:  2012-12-23       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.